Other Clinical Trial - Use of Cheetah® Cardiac Monitoring System to Guide

Clinical Trial Summary

This is a single site pilot randomized, controlled, trial randomizing patients with PE with severe features to one of 2 groups: - 24 hours of postpartum magnesium sulfate (current arbitrary standard of care) - Using the Cheetah® device to aid in an individualized duration of magnesium sulfate.

See also
Status	Clinical Trial	Phase
Terminated	`NCT03872336` - Acute Labetalol Use in Preeclampsia	Phase 4
Terminated	`NCT03877692` - Acute Control of Chronic Hypertension	Phase 4
Completed	`NCT05096728` - Nifedipine Dosing Daily vs Twice a Day for Pre-eclampsia With Severe Features (NOPPI)

See also

Status

Clinical Trial

Phase

Terminated

NCT03872336 - Acute Labetalol Use in Preeclampsia

Phase 4

Terminated

NCT03877692 - Acute Control of Chronic Hypertension

Phase 4

Completed

NCT05096728 - Nifedipine Dosing Daily vs Twice a Day for Pre-eclampsia With Severe Features (NOPPI)

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT04474704
Study type	Interventional
Source	Ohio State University
Contact
Status	Completed
Phase	N/A
Start date	February 22, 2021
Completion date	May 31, 2022

Use of Cheetah® Cardiac Monitoring System to Guide Discontinuation of Magnesium Sulfate in Women With Severe Preeclampsia

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms